Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008

Author:

Kuijper E J1,Barbut F2,Brazier J S3,Kleinkauf N4,Eckmanns T4,Lambert M L5,Drudy D6,Fitzpatrick F7,Wiuff C8,Brown D J9,Coia J E9,Pituch H10,Reichert P11,Even J11,Mossong J11,Widmer A F12,Olsen K E13,Allerberger F14,Notermans D W15,Delmée M16,Coignard B17,Wilcox M18,Patel B19,Frei R20,Nagy E21,Bouza E22,Marin M10,Åkerlund T23,Virolainen-Julkunen A24,Lyytikäinen O24,Kotila S24,Ingebretsen A25,Smyth B26,Rooney P27,Poxton I R28,Monnet D. L.29

Affiliation:

1. National Reference Laboratory for Clostridium difficile. Leiden University Medical Center, Leiden, The Netherlands

2. National Reference Center for Clostridium difficile, Saint-Antoine Hospital, Paris, France

3. Anaerobe Reference Laboratory, National Public Health Service for Wales Cardiff, University Hospital of Wales, Cardiff, United Kingdom

4. Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

5. Epidemiology Unit, Scientific Institute of Public Health, Brussels, Belgium

6. Centre for Food Safety, Food Science and Veterinary Medicine, University College Dublin, Dublin, Ireland

7. Health Protection Surveillance Centre and Beaumont Hospital, Dublin, Ireland

8. Health Protection Scotland, Section for Healthcare Associated Infection and Infection Control, Glasgow, United Kingdom

9. Scottish Clostridium difficile Reference Service, Stobhill Hospital, Glasgow, United Kingdom

10. Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland

11. Division of Microbiology, National Public Health Laboratory, Luxembourg

12. Division of Infectious diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland

13. National Reference Laboratory for Enteropathogens, Statens Serum Institut, Copenhagen, Denmark

14. Österreichische Agentur für Gesundheit und Ernährungssicherheit (Austrian Agency for Health and Food Safety; AGES), Vienna, Austria

15. Centrum Infectieziektebestrijding (Centre for Infectious Disease Control; CIb), Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment; RIVM), Bilthoven, The Netherlands

16. Microbiology Department, Saint-Luc University Hospital, Brussels, Belgium

17. Departement of Infectious Diseases, Institut de Veille Sanitaire (National Public Health Institute; InVS), Saint-Maurice, France

18. Clostridium difficile Ribotyping Network for England (CDRNE), Health Protection Agency, Reference Leeds General Infirmary, Leeds, United Kingdom

19. Health Protection Agency, London, United Kingdom

20. Microbiology Laboratory, University Hospital, Basel, Switzerland

21. Department of Clinical Microbiology, Faculty of Medicine, University of Szeged, Szeged, Hungary

22. Department of Medical Microbiology, University General Hospital Gregorio Maranon, Madrid, Spain

23. Smittskyddsinstitutet (Swedish Institute for Infectious Disease Control; SMI), Solna, Sweden

24. Kansanterveyslaitos (National Public Health Institute; KTL), Helsinki, Finland

25. Department of Infection Prevention, Rikshospitalet, Oslo, Norway

26. Health Protection Agency, Communicable Disease Surveillance Centre (Northern Ireland), Belfast, United Kingdom

27. Microbiology Laboratory Belfast City Hospital, Belfast, United Kingdom

28. Medical Microbiology, Centre for Infectious Diseases, University of Edinburgh College of Medicine and Veterinary Medicine, Edinburgh, United Kingdom

29. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Abstract

Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and significant mortality have been related to the emergence of a new, hypervirulent C. difficile strain in North America and Europe. This emerging strain is referred to as PCR ribotype 027 (Type 027). Since 2005, individual countries have developed surveillance studies about the spread of type 027. C. difficile Type 027 has been reported in 16 European countries. It has been responsible for outbreaks in Belgium, Germany, Finland, France, Ireland, Luxembourg, The Netherlands, Switzerland and the United Kingdom (England, Wales, Northern Ireland and Scotland). It has also been detected in Austria, Denmark, Sweden, Norway, Hungary, Poland and Spain. Three countries experienced imported patients with CDI due to Type 027 who acquired the infection abroad. The antimicrobial resistance pattern is changing, and outbreaks due to clindamycin-resistant ermB positive Type 027 strains have occurred in three European countries. Ongoing epidemiological surveillance of cases of CDI, with periodic characterisation of the strains involved, is required to detect clustering of cases in time and space and to monitor the emergence of new, highly virulent clones.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3